XW033G5Introduction of Sarilumab into Peripheral Vein, Percutaneous Approach, New Technology Group 5

New Technology›Anatomical Regions›Introduction
  • Billable / Specific Code
ICD-10-PCS XW033G5
CMS Source: FY 2027 ICD-10-PCS dataset. Effective Oct 1, 2026 – Sep 30, 2027.FacebookXLinkedInPrint

XW033G5 is a billable ICD-10-PCS procedure code for Introduction of Sarilumab into Peripheral Vein, Percutaneous Approach, New Technology Group 5. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027).

Code Identity

ICD-10-PCS Code
XW033G5
Billable Status
Yes — Valid for Submission
Code Describes
Introduction of Sarilumab into Peripheral Vein, Percutaneous Approach, New Technology Group 5
Short Description
Introduce Sarilumab in Periph Vein, Perc, New Tech 5
Parent Code
XW0

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body SystemWAnatomical Regions
3Operation0Introduction
4BodyPart3Peripheral Vein
5Approach3Percutaneous
6Device/Substance/TechnologyGSarilumab
7Qualifier5New Technology Group 5

Similar Procedure Codes

Questions About XW033G5

Is XW033G5 a billable code?

Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Sarilumab into Peripheral Vein, Percutaneous Approach, New Technology Group 5 on inpatient claims from October 1, 2026 through September 30, 2027.

What do the characters in XW033G5 mean?

The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character 3 is the BodyPart (Peripheral Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character G is the Device/Substance/Technology (Sarilumab); the 7th character 5 is the Qualifier (New Technology Group 5).